Skip to main content
See every side of every news story
Published loading...Updated

Ch-Schluss: Thanks to Pharma and Ubs Clear in the Plus

Summary by Moneycab
The Swiss stock market ended the sixth consecutive session on Friday with a profit. On the one hand, the strong pharmaceutical values and the price gains of Grossbank UBS were the reasons for this.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

The Swiss stock market ended the sixth consecutive session on Friday with a profit. On the one hand, the strong pharmaceutical values and the price gains of Grossbank UBS were the reasons for this.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Moneycab broke the news in on Friday, October 3, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal